Список литературы к главе 2

1. Damm J.A., Asbjornsdottir B., Callesen N.F., Mathiesen J.M., Ringholm L. et al. Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome // Diabetes Care. 2013. Vol. 36, N 11. P. 3489–3494. DOI: 10.2337/dc13-1031.

2. McCance D.R., Holmes V.A., Maresh M.J., Patterson C.C., Walker J.D. et al. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial // Lancet. 2010. Vol. 376, N 9737. P. 259–266. DOI: 10.1016/s0140-6736(10)60630-7.

3. Ekbom P., Damm P., Feldt-Rasmussen B., Feldt-Rasmussen U., Mølvig J., Mathiesen E.R. Pregnancy outcome in type 1 diabetic women with microalbuminuria // Diabetes Care. 2001. Vol. 24, N 10. P. 1739–1744. DOI: 10.2337/diacare.24.10.1739.

4. Боровик Н.В., Потин В.В., Рутенбург Е.Л. Диабетические микрососудистые осложнения (ретинопатия и нефропатия) и беременность // Журнал акушерства и женских болезней. 2013. Т. 62, № 2. С.75–82.

5. Klemetti M.M., Laivuori H., Tikkanen M., Nuutila M., Hiilesmaa V., Teramo K. Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988–2011 // Diabetologia. 2015. Vol. 58, N 4. P. 678–686. DOI: 10.1007/s00125-014-3488-1.

6. The Diabetes Control and Complications Trial Research Group, Nathan D.M., Genuth S., Lachin J., Cleary P., Crofford O. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus // N. Engl. J. Med. 1993. N 329. P. 977–986. DOI: 10.1056/NEJM199309303291401.

7. Biesenbach G., Grafinger P., Stoger H., Zazgornik J. How pregnancy influences renal function in nephropathic type 1 diabetic women depends on their pre-conceptional creatinine clearance // J. Nephrol. 1999. N 12. P. 41–46. DOI: 10.1007/bf00400946.

8. Reece E.A., Leguizamon G., Homko C. Pregnancy performance and outcomes associated with diabetic nephropathy // Am. J. Perinatol. 1998. N 15. P. 413–421. DOI: 10.1055/s-2007-993968.

9. The Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial // Diabetes Care. 2000. Vol. 23, N 8. P. 1084–1091. DOI: 10.2337/diacare.23.8.1084

10. Verier-Mine O., Chaturvedi N., Webb D., Fuller J.H. Is pregnancy a risk factor for microvascular complications? The EURODIAB Prospective Complications Study // Diabet. Med. 2005. Vol. 22. P. 1503–1509. DOI: 10.1111/j.1464-5491.2005.01682.x.

11. Gordon M., Landon M.B., Samuels P., Hissrich S., Gabbe S.G. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy // Obstet. Gynecol. 1996. Vol. 87. P. 401–409. DOI: 10.1016/0029-7844(95)00420-3.

12. Imbasciati E., Gregorini G., Cabiddu G., Gammaro L., Ambroso G. et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes // Am. J. Kidney Dis. 2007. Vol. 49. P. 753–762. DOI: 10.1053/j.ajkd.2007.03.022.

13. Biesenbach G., Stöger H., Zazgornik J. Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type I diabetic patients with impaired renal function // Nephrol. Dial. Transplant. 1992. Vol. 7. P. 105–109. DOI: 10.1093/oxfordjournals.ndt.a092077.

14. Purdy L.P., Hantsch C.E., Molitch M.E., Metzger B.E., Phelps R.L. et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency // Diabetes Care. 1996. Vol. 19. P. 1067–1074. DOI: 10.2337/diacare.19.10.1067.

15. Mackie A.D., Doddridge M.C., Gamsu H.R., Brudenell J.M., Nicolaides K.H., Drury P.L. Outcome of pregnancy in patients with insulin-dependent diabetes mellitus and nephropathy with moderate renal impairment // Diabet. Med. 1996. Vol. 13. P. 90–96. DOI: 10.1002/(SICI)1096-9136(199601)13:1 <90::AID-DIA992>3.0.CO;2-M.

16. Rossing K., Jacobsen P., Hommel E., Mathiesen E., Svenningsen A. et al. Pregnancy and progression of diabetic nephropathy // Diabetologia. 2002. Vol. 45. P. 36–41. DOI: 10.1007/s125-002-8242-4.

17. Piccoli G.B., Clari R., Ghiotto S., Castelluccia N., Colombi N. et al. Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study // Rev. Diabet. Stud. 2013. Vol. 10. P. 6–26. DOI: 10.1900/RDS.2013.10.6.

18. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S. et al. Major congenital malformations after first-trimester exposure to ACE inhibitors // N. Engl. J. Med. 2006. Vol. 354. P. 2443–2451. DOI: 10.1056/NEJMoa055202.

19. Li D.K., Yang C., Andrade S., Tavares V., Ferber J.R. et al. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study // BMJ. 2011. Vol. 343. P. d5931. DOI: 10.1136/bmj.d5931.

20. Bullo M., Tschumi S., Bucher B.S., Bianchetti M.G., Simonetti G.D. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review // Hypertension. 2012. Vol. 60. P. 444–450. DOI: 10.1161/HYPERTENSIONAHA.112.196352.

21. American Diabetes Association. Management of diabetes in pregnancy: standards of medical care in Diabetes-2019 // Diabetes Care. 2019. Vol. 42. Suppl. 1. P. S165–S172. DOI: 10.2337/dc19-S014.

22. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE guideline 3 // National Institute of Clinical and Health Excellence: [site]. URL: https://www.nice.org.uk/guidance/ng3.

23. Carr D.B., Koontz G.L., Gardella C., Holing E.V., Brateng D.A. et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery // Am. J. Hypertens. 2006. Vol. 19. P. 513–519. DOI: 10.1016/j.amjhyper.2005.12.010.

24. Fullerton B., Jeitler K., Seitz M., Horvath K., Berghold A., Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus // Cochrane Database Syst. Rev. 2014. Vol. 2. P. CD009122. DOI: 10.1002/14651858.

25. Shurraw S., Hemmelgarn B., Lin M., Majumdar S.R., Klarenbach S. et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study // Arch. Intern. Med. 2011. Vol. 171, N 21. P. 1920–1927 DOI: 10.1001/archinternmed.2011.537.

26. Айламазян Э.К., Абашова Е.И., Коган И.Ю. и др. Сахарный диабет и репродуктивная система женщины: руководство для врачей. Москва: ГЭОТАР-Медиа, 2019. 432 с.

27. Газизова Г.Р. Маркеры воспаления диабетической нефропатии у беременных с сахарным диабетом 1-го типа: дис. ... канд. мед. наук. Санкт-Петербург, 2015. 146 с.

28. Morrison J.L., Hodgson L.A., Lim L.L., Al-Qureshi S. Diabetic retinopathy in pregnancy: a review // Clin. Exp. Ophthalmol. 2016. Vol. 44, N 44. P. 321–334. DOI: 10.1111/ceo.12760.

29. Rasmussen K.L., Laugesen C.S., Ringholm L., Vestgaard M., Damm P., Mathiesen E.R. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes // Diabetologia. 2010. Vol. 53, N 6. P. 1076–1083.

30. Rahman W., Rahman F.Z., Yassin S., Al-Suleiman S.A., Rahman J. Progression of retinopathy during pregnancy in type 1 diabetes mellitus // Clin. Experiment. Ophthalmol. 2007. Vol. 35. P. 231–236.

31. Arun C.S., Taylor R. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes // Diabetologia. 2008. Vol. 51, N 6. P. 1041–1045. DOI: 10.1007/s00125-008-0994-z.

32. Holmes V.A., Young I.S., Patterson C.C., Pearson D.W., Walker J.D., Maresh M.J. et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial // Diabetes Care. 2011. Vol. 34, N 8. P. 1683–1688. DOI: 10.2337/dc11-0244.

33. Bourry J., Courteville H., Ramdane N., Drumez E., Duhamel A., Subtil D. et al. Progression of diabetic retinopathy and predictors of its development and progression during pregnancy in patients with type 1 diabetes: a report of 499 pregnancies // Diabetes Care. 2021. Vol. 44, N 1. P. 181–187. DOI: 10.2337/dc20-0904.

34. Gordin D., Kaaja R., Forsblom C., Hiilesmaa V., Teramo K., Groop P.H., FinnDiane Study Group. Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life // Acta Diabetol. 2013. Vol. 50. P. 781–787.

35. Vestgaard M., Ringholm L., Laugesen C., Rasmussen K.L., Damm P., Mathiesen E.R. Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes // Diabet. Med. 2010. Vol. 27. Р. 431–435.